NCT00080054View on ClinicalTrials.gov

A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

Not specified

Conditions
GliomaGlioblastomaAstrocytomaOligodendrogliomaBrain Neoplasm
Interventions
DRUG

Motexafin Gadolinium Injection

Trial Locations (1)

85013

Barrow Neurological Institute, Phoenix

Sponsors

Lead Sponsor

Pharmacyclics LLC.
All Listed Sponsors
lead

Pharmacyclics LLC.

INDUSTRY